Using Adverse Outcome Pathways (AOP) to address combined exposures to chemicals with relevant effect-biomarkers; Case study – Vitellogenin induction, mixture thresholds in male fish

Villeneuve, Daniel

doi:10.23645/epacomptox.28509203.v1

Using Adverse Outcome Pathways (AOP) to address combined exposures to chemicals with relevant effect-biomarkers; Case study – Vitellogenin induction, mixture thresholds in male fish

presentation

posted on 2025-02-27, 21:06 authored by Daniel Villeneuve

Presented to the working party on hazard assessment third meeting project "Using Adverse Outcome Pathways (AOP) to address combined exposures to chemicals with relevant effect-biomarkers" on 5/13/24

Search for CCTE records in EPA’s Science Inventory by typing in the title at this link.

https://cfpub.epa.gov/si/si_public_search_results.cfm?advSearch=true&showCriteria=2&keyword=CCTE&TIMSType=&TIMSSubTypeID=&epaNumber=&ombCat=Any&dateBeginPublishedPresented=07/01/2017&dateEndPublishedPresented=&dateBeginUpdated=&dateEndUpdated=&DEID=&personName=&personID=&role=Any&journalName=&journalID=&publisherName=&publisherID=&sortBy=pubDate&count=25

History

Usage metrics

Keywords

Adverse Outcome Pathways (AOPs)Chemical Mixtures.Water Monitoring Occupational Health

Licence

CC0

Using Adverse Outcome Pathways (AOP) to address combined exposures to chemicals with relevant effect-biomarkers; Case study – Vitellogenin induction, mixture thresholds in male fish

History

Usage metrics

Categories

Keywords

Licence

Exports